Blood Donation Does Not Reduce Cancer Rates
Current evidence does not support that regular blood donation reduces cancer incidence in the general population. While some observational studies have shown lower cancer rates among blood donors, these findings are primarily explained by the "healthy donor effect" (HDE)—blood donors are inherently healthier individuals who are screened and selected for good health, rather than donation itself providing protective benefits 1, 2.
Key Evidence Analysis
Most Recent High-Quality Research
The 2024 Australian study using advanced statistical methods (inverse probability weighting and doubly robust estimators) to specifically control for the healthy donor effect found no statistically significant differences in cancer risk between high-frequency and low-frequency blood donors for 2:
- Gastrointestinal/colorectal cancer: Risk ratio 1.25 (0.83-1.68)
- Breast cancer: Risk ratio 0.87 (0.48-1.26)
- Haematological cancers: Risk ratio 0.97 (0.55-1.40)
A 2026 systematic review examining this question concluded that once properly adjusted for the healthy donor effect, most studies found no significant association between blood donation and overall cancer risk 1.
Why Earlier Studies Showed Apparent Benefits
Older observational studies (1990,2008) reported lower cancer rates among donors 3, 4, but these findings are confounded by:
- Selection bias: Blood donors must pass health screenings and are typically healthier baseline populations
- Surveillance bias: Donors receive regular health monitoring that may detect cancers earlier or identify healthier individuals
- Lifestyle factors: Donors tend to have healthier behaviors independent of donation
The 2008 Swedish-Danish study attempted dose-response analysis within donors and found inconsistent results across latency periods, with the authors themselves noting this "casts doubt on an apparent association between reduced cancer risk and iron loss" 3.
Concerning Findings
The 2022 Chinese study found increased brain cancer risk among male donors (RR 1.19,95% CI: 1.06-1.29) 5, and the 2008 study identified increased non-Hodgkin lymphoma risk with frequent plasma donation (OR 2.14,95% CI: 1.22-3.74) 3. These warrant caution against promoting donation as cancer prevention.
Clinical Bottom Line
Do not recommend blood donation as a cancer prevention strategy. The apparent protective associations in earlier studies reflect donor selection criteria rather than biological effects of donation. Evidence-based cancer prevention should focus on established interventions: tobacco cessation, maintaining healthy weight, physical activity, limiting alcohol, and appropriate cancer screening 6.
Important Caveats
- Blood donation remains safe for appropriately screened donors and serves critical healthcare needs
- Donors should not be discouraged based on cancer concerns when medically eligible
- The iron depletion hypothesis (that reducing iron stores might reduce cancer risk) lacks consistent clinical evidence despite biological plausibility 3
- Any health benefits donors perceive are likely psychological rather than physiological 7